Evidence map›Paper›PMID 41774260›Full record

ArticleEuropean journal of pediatrics2026

Pediatricians' approaches to communicating side effects: a national survey.

Anna de Geus, Dunya Seinen, Marc A Benninga, SPIN, the General Pediatrics Research Network of the Dutch Association for Pediatrics, Arine M Vlieger

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna de GeusDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Amsterdam University Medical Centre, Emma's Children Hospital, University of Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-2282-0128
Dunya SeinenDepartment of Pediatrics, St. Antonius Hospital, Soestwetering 1, 3543 AZ, Utrecht, the Netherlands.
Marc A BenningaDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Amsterdam University Medical Centre, Emma's Children Hospital, University of Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0001-9406-9188
SPIN, the General Pediatrics Research Network of the Dutch Association for Pediatrics
Arine M VliegerDepartment of Pediatrics, St. Antonius Hospital, Soestwetering 1, 3543 AZ, Utrecht, the Netherlands. arine@vlieger.nl.ORCID http://orcid.org/0000-0002-3869-2896

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most parents and adolescents want comprehensive information about potential side effects (SE) of medication. However, such information can sometimes trigger side effects due to negative expectations: the so-called nocebo effect. To develop evidence-based strategies that meet information needs while minimizing nocebo effects, this study examined how pediatricians currently communicate about side effects when prescribing medications. A national multicenter survey among pediatricians and pediatric residents was performed. A 9-item questionnaire assessed education on SE communication, awareness of the nocebo effect, and communication about SE for ondansetron, inhaled steroids, and amoxicillin/clavulanic acid. A total of 438 respondents were included (80.1% pediatricians, 19.9% pediatric residents). Only 6.8% had received education on SE communication during medical school. The extent of information on SEs varied widely per medication type. Nearly half of the respondents (48.9%) never inquired about parents' or patients' informational needs on side effects. They were significantly more likely to never discuss side effects for all studied medications compared to those who did inquire needs. Awareness of the nocebo effect and its consideration in communication was reported by 41.3% of respondents. These respondents provided significantly more often minimal instead of extensive information compared to respondents not aware of the nocebo effect and/or not considering it in their communication.

conclusionThere is substantial variability in pediatricians' approaches to communicating SEs when prescribing medications, alongside a lack of education on this topic. These findings underscore the need for standardized, evidence-based guidelines and training supporting transparent communication while minimizing the nocebo effect. WHAT IS KNOWN: • Poor adherence to treatment regimens is a major global problem, with side effects being an important contributor. • The way physicians discuss potential side effects can itself influence the occurrence of side effects through the nocebo effect. WHAT IS NEW: • There is substantial variability among physicians in how side effects are communicated, depending on medication type, information framing, and tailoring to patients' informational needs. • Formal education on discussing side effects during medical school or postgraduate training is scarce among pediatricians and residents.

Indexed as

CommunicationDrug-Related Side Effects and Adverse ReactionsPediatriciansPhysician-Patient RelationsPractice Patterns, Physicians'AdultFemaleHumansMaleMiddle AgedNocebo EffectPediatricsSurveys and QuestionnairesCommunicationMedication informationNoceboPediatricsPhysician–patient communicationSide effects

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.